COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,669 Articles (22,913 medRxiv, 8,756 bioRxiv)

Most recent first Previous |  Page 1243: Articles 12421-12430  | Next

Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patients
LaSalle, T. J., Gonye, A. L. K., Freeman, S. S., Kaplonek, P., Gushterova, I., Kays, K. R., Manakongtreecheep, K., Tantivit, J., Rojas-Lopez, M., Russo, B. C., Sharma, N., Thomas, M. F., Lavin-Parsons, K. M., Lilly, B. M., Mckaig, B. N., Charland, N. C., Khanna, H. K., Lodenstein, C. L., Margolin, J. D., Blaum, E. M., Lirofonis, P. B., Sonny, A., Bhattacharyya, R. P., Parry, B. A., Goldberg, M. B., Alter, G., Filbin, M. R., Villani, A. C., Hacohen, N., Sade-Feldman, M.
10.1101/2021.10.04.463121 — Posted: 2021-10-05
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
Xu, M., Pradhan, M., Gorshkov, K., Petersen, J. D., Shen, M., Guo, H., Zhu, W., Klumpp-Thomas, C., Michael, S., Itkin, M., Itkin, Z., Straus, M. R., Zimmerberg, J., Zheng, W., Whittaker, G., Chen, C. Z.
10.1101/2021.10.04.463106 — Posted: 2021-10-05
Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease Ctsl
Cui, Z., Zeng, C., Huang, F., Yuan, F., Yan, J., Zhao, Y., Huang, J., Staats, H. F., Everitt, J. I., Sempowski, G. D., Wang, H., Dong, Y., Liu, S.-L., Wang, Q.
10.1101/2021.10.03.462915 — Posted: 2021-10-05
Oral and intranasal Ad5 SARS-CoV-2 vaccines decrease disease and viral transmission in a golden hamster model
Langel, S. N., Johnson, S., Martinez, C. I., Tedjakusuma, S. N., Peinovich, N., Dora, E. G., Kuehl, P. J., Irshad, H., Barrett, E. G., Werts, A., Tucker, S. N.
10.1101/2021.10.03.462919 — Posted: 2021-10-05 Discussion: Onsite
Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelae
Thompson, R. C., Simons, N. W., Wilkins, L., Cheng, E., Del-Valle, D. M., Hoffman, G. E., Fennessy, B., Mouskas, K., Francoeur, N. J., Johnson, J. S., Lepow, L., Le Berichel, J., Chang, C., Beckmann, A. G., Wang, Y.-c., Nie, K., Zaki, N., Tuballes, K., Barcessat, V., Cedillo, M. A., Huckins, L., Roussos, P., Marron, T. U., The Mount Sinai COVID-19 Biobank Team, , Glicksberg, B. S., Nadkarni, G., Gonzalez-Kozlova, E., Kim-Schulze, S., Sebra, R., Merad, M., Gnjatic, S., Schadt, E. E., Charney, A. W., Beckmann, N. D.
10.1101/2021.10.04.21264434 — Posted: 2021-10-05
Adverse events following COVID-19 vaccination in young Japanese people: A case-control study of the risk of systemic adverse events by a questionnaire surveyShort title: COVID-19 vaccine adverse events in young Japanese
Suehiro, M., Okubo, S., Nakajima, K., Kanda, K., Hayakawa, M., Oiso, S., Kabashima, T., Fujita, H., Ando, Y., Muro, T.
10.1101/2021.10.01.21264393 — Posted: 2021-10-05
Increase in preterm stillbirths and reduction in iatrogenic preterm births for fetal compromise: a multi-centre cohort study of COVID-19 lockdown effects in Melbourne, Australia
Hui, L., Marzan, M. B., Potenza, S., Rolnik, D. L., Pritchard, N., Said, J. M., Palmer, K. R., Whitehead, C. L., Sheehan, P. M., Ford, J., Mol, B. W., Walker, S. P.
10.1101/2021.10.04.21264500 — Posted: 2021-10-05 Discussion: Onsite
Circulating proteins to predict adverse COVID-19 outcomes
Su, C.-Y., Zhou, S., Gonzalez-Kozlova, E., Butler-Laporte, G., Brunet-Ratnasingham, E., Nakanishi, T., Jeon, W., Morrison, D., Laurent, L., Afilalo, J., Afilalo, M., Henry, D., Chen, Y., Carrasco-Zanini, J., Farjoun, Y., Pietzner, M., Kimchi, N., Afrasiabi, Z., Rezk, N., Bouab, M., Petitjean, L., Guzman, C., Xue, X., Tselios, C., Vulesevic, B., Adeleye, O., Abdullah, T., Almamlouk, N., Moussa, Y., DeLuca, C., Duggan, N., Schurr, E., Brassard, N., Durand, M., Marie Del Valle, D., Thompson, R., Cedillo, M. A., Schadt, E., Nie, K., Simons, N. W., Mouskas, K., Zaki, N., Patel, M., Xie, H., Harris, J., Marvin, R., Cheng, E., Tuballes, K., Argueta, K., Scott, I., The Mount Sinai COVID Biobank Team, , Greenwood, C. M. T., Paterson, C., Hinterberg, M., Langenberg, C., Forgetta, V., Pineau, J., Mooser, V., Marron, T., Beckmann, N., Kenigsberg, E., Kim-schulze, S., Charney, A. W., Gnjatic, S., Kaufmann, D. E., Merad, M., Richards, J. B.
10.1101/2021.10.04.21264015 — Posted: 2021-10-05
Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity
Garry, E. M., Weckstein, A. R., Quinto, K., Lasky, T., Chakravarty, A., Leonard, S., Vititoe, S. E., Easthausen, I. J., Rassen, J. A., Gatto, N. M.
10.1101/2021.10.04.21264513 — Posted: 2021-10-05
Adverse events of special interest for COVID-19 vaccines - background incidences vary by sex, age and time period and are affected by the pandemic
Nyberg, F., Lindh, M., Vanfleteren, L. E., Hammar, N., Wettermark, B., Sundström, J., Santosa, A., Kirui, B. K., Gisslen, M.
10.1101/2021.10.04.21263507 — Posted: 2021-10-05 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).